35 New Strategic Partnerships Fueling Comodo CA's Booming Channel Growth
CLIFTON, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Comodo CA, a worldwide leader in digital identity solutions, today announced the addition of 35 new strategic partnerships, positioning its channel program for another record year in 2018. The new partner relationships come amid continued momentum Comodo CA is seeing across its business. New partners include:
Wix.com, Secure128, AdwebTech, DonDominio , and GeoCerts.
"The record-setting growth we've seen in the last year is testament to the clear value partners are experiencing with our partner program," said Michael Fowler, Comodo CA President of Channels. "Since 2001 we've been the leader in helping partners succeed, breaking new ground in building and executing a best-in-class channel program. These new strategic partners have been exclusive to our competitors for more than a decade and are globally diverse, some are the largest providers within their specific regions. This momentum is of course assisting our expansion within these net- new verticals and geographies, and we are delighted to be part of their success."
To support the rapidly growing channel momentum, Comodo CA has made significant enhancements to its global Channel Partner Program. Over the past year it has bolstered its executive team with industry veterans, built up its sales and marketing teams, and improved pre- and post-support functions globally. Additionally, channel partners are being rewarded with new financial incentives such as the Annual Growth Rebate Program, increased revenue opportunities for partners with enterprise solutions, pre-qualified leads, free competitor replacement program and Marketing Development Funds (MDF). These new strategic partners are coming to Comodo CA for differentiated value.
Quotes from newly signed partners:
"Comodo CA's infrastructure and technical capabilities help us to deploy and manage security for our customers at scale. We needed a solution that could handle volume, as well as provide dedicated service and support. This partnership provides a valuable layer of security features for our customers as part of their Wix website service." - Dror Shaked, SVP of Business Development at Wix
"Comodo CA's product offerings will help Adwebtech expand our portfolio of cybersecurity solutions, adding to our SSL, digital signatures and managed public key infrastructure offerings. With the growing global onslaught of cybercrime, our customers are eager to improve their digital security to avoid business and financial harm. Comodo CA's solutions will help us deliver even greater value to our customers." - Apurva Mody, CEO at Adwebtech
"We choose Comodo CA for their suite of innovative solutions that easily integrate into our core offering. What makes the partnership so successful is the support and 1:1 attention we are seeing from everyone across the organization. They are all dedicated to our success." - Anthony Capodicasa, CEO of Secure128
"We pride ourselves on providing customers with market-leading solutions at a fair price, followed up by outstanding customer support; the partnership with Comodo CA is a strong contributor to that mission. Comodo CA's partner-first approach and ability to bring new, innovative security solutions to market make the company an ideal partner for us." - Scott Rogers CEO of GeoCerts
"Comodo CA is the perfect cybersecurity partner for us. We can now provide market-leading security solutions to our end users and resellers with the support of the number 1 online trust provider." - Marc Gelabert, CRO of DonDominio
About Comodo CA
A trusted advisor by enterprises globally for more than two decades, Comodo CA provides digital identity solutions for businesses of all sizes - protecting their employees, customers, intellectual property and overall brand - from damages caused by fraudsters impersonating people and devices.
As the largest commercial certificate authority with over 100 million SSL certificates issued worldwide, Comodo CA has the experience and performance to meet the growing need to secure transactions and create online trust. For more information, visit ComodoCA.com or via twitter @Comodo_SSL.
Contact: Lisa Johnson email@example.com 425-766-8736
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Comodo CA via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Taconic Biosciences Launches New Inflammatory Bowel Disease Models19.4.2018 14:00 | Pressemelding
RENSSELAER, N.Y., April 19, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis mouse models. The new knockout models were created on Taconic's B6 (C57BL/6NTac) and BALB/c (BALB/cAnNTac) backgrounds, and are available at both the Excluded Flora (EF) and Germ Free (GF) health standards. Beyond the scientific benefits, Taconic is also making them easy to access by offering these models to commercial, contract research organization (CRO), and academic institutions under a simple label license. This represents a departure from the license requirements for Il10 knockouts from other animal model providers. "In order for animal models to drive drug discovery they need to be both
Cisco ACI Is Data Center Solution of Choice for Service Providers Worldwide19.4.2018 14:00 | Pressemelding
Service providers deliver new cloud services more quickly and offer superior customer experience with the help of Cisco Application Centric Infrastructure SAN JOSE, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- Providing secure, differentiated and rapidly delivered cloud services to customers is a crucial requirement for today's service providers. To meet cloud infrastructure demands, global service providers are increasingly turning to the Cisco® Application Centric Infrastructure (Cisco ACI(TM)) , the industry-leading software-defined networking (SDN) solution. Cisco ACI reduces operational costs with an automated, policy-based programmable architecture, while improving scalability and security. In addition, new Cisco ACI multi-site management capability helps service providers to connect and manage multiple geographically distributed Cisco ACI fabrics and to move and manage workloads with a single pane of glass. Cisco ACI is being deployed worldwide by service providers such as NTT Com
FinancialForce Extends Professional Services Automation Leadership With its Spring 2018 Release19.4.2018 14:00 | Pressemelding
New features empower services organizations to run their businesses with greater predictability, assign best-fit resources at scale, and forecast projects with 360-degree insight. SAN FRANCISCO, April 19, 2018 (GLOBE NEWSWIRE) -- FinancialForce, the number one customer-centric ERP cloud vendor built on the Salesforce Platform, announced the availability of its latest version of Professional Services Automation, the highest customer-rated PSA solution for enterprise organizations. The Spring 2018 Release of PSA brings new functional capabilities to accelerate project staffing speed and accuracy; unify people and project data; enable better forecasting decisions; and enhance the overall user experience using the Salesforce Lightning framework. Fast, Accurate Resource Mapping With the Spring 2018 Release of PSA, project and resource managers can identify and assign best-fit resources with greater speed and accuracy. Through advanced skills filtering and search capabilities, including part
SpeeDx receives FDA clearance for Mycoplasma genitalium product19.4.2018 14:00 | Pressemelding
SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) -- SpeeDx's Resistance Plus ® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company's recently incorporated US entity, SpeeDx Inc. The announcement coincides with the FDA registration of the Australian parent company - SpeeDx Pty Ltd - as a Medical Device Manufacturing Establishment, and clinical trials remain on-track for the Resistance Plus MG assay.* The Resistance Plus MG Positive Control kit contains synthetic DNA to simulate Mycoplasma genitalium, as well as five mutations known to confer resistance to macrolide antibiotics. Macrolide-resistant M. genitalium is a challenging sexually transmitted infection (STI), and global management guidelines are currently being adapted to deal with the rise in resistance. "This is an important product in our portfolio," said Elisa Mokany, Chief Technology Officer for SpeeDx. "M. genitalium is very difficult
SEMAFO: Construction of Boungou Mine 91% Complete19.4.2018 13:00 | Pressemelding
Commissioning Advancing to Plan MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) announced that construction of the Boungou Mine in Burkina Faso is 91% complete, and commissioning activities are advancing well with 10% already completed at the end of March. Since launch of commissioning at the end of February, the crushing circuit equipment and water services have been tested and commissioned. The reclaim and grinding circuits, reagent and oxygen plants are also undergoing testing. Wet commissioning began at the end of March with the Corporation pumping water from the water storage facility to the raw water tanks for the processing plant. We are still in line to achieve our first gold pour early in the third quarter of 2018. As at March 31, 2018, the following milestones had been reached: Development on budget with US$194 million of the US$231 million capital expenditure incurred Construction of the mine 91% complete Completion of 98% of structural steel and
Merus to Report Full Year 2017 Financial Results and Corporate Developments on April 26, 201819.4.2018 13:00 | Pressemelding
Conference call scheduled for Thursday, April 26, 2018, at 8:30 a.m. ET UTRECHT, The Netherlands, April 19, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the Company will report full year 2017 financial results on Thursday, April 26, 2018. Merus' management team will host a conference call and audio webcast at 8:30 a.m. ET on Thursday, April 26, 2018, to discuss the financial results and recent clinical and corporate developments. To participate in the call, please dial (877) 260-1463 (U.S.) or (706) 643-5907 (international) and reference conference ID 6184636. A live webcast will be available on the Investors page of the Company's website, http://www.merus.nl. An archived webcast replay will be available for 90 days. About Merus N.V. Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeut
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom